The event will take place in Team Finland House (Porkkalankatu 1, Helsinki). It is also possible to follow the event...
Read more
We published
Cardiovascular disease (CVD) is Europe’s number one killer, taking the lives of 5,000 Europeans every day. A new report by PwC, commissioned by the EFPIA CVD Network, set out to understand the impact of the pandemic on the 60 million CVD patients living in Europe. More than that, the report – Boosting cardiovascular health in Europe: towards more resilient and equitable healthcare– offers a series of concrete recommendations designed to better position European health systems to cope with future crises.
The continent is eager to capitalise on BioNTech’s Covid-19 success — but matching the scale of US hubs will be hard...
Read more
About the EFPIA newsletter
The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.